Disruption of the Sarcoglycan–Sarcospan Complex in Vascular Smooth Muscle
- 1 August 1999
- Vol. 98 (4), 465-474
- https://doi.org/10.1016/s0092-8674(00)81975-3
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Membrane Targeting and Stabilization of Sarcospan Is Mediated by the Sarcoglycan SubcomplexThe Journal of cell biology, 1999
- A first missense mutation in the delta sarcoglycan gene associated with a severe phenotype and frequency of limb-girdle muscular dystrophy type 2F (LGMD2F) in Brazilian sarcoglycanopathies.Journal of Medical Genetics, 1998
- Progressive Muscular Dystrophy in α-Sarcoglycan–deficient MiceThe Journal of cell biology, 1998
- γ-Sarcoglycan Deficiency Leads to Muscle Membrane Defects and Apoptosis Independent of DystrophinThe Journal of cell biology, 1998
- MLP-Deficient Mice Exhibit a Disruption of Cardiac Cytoarchitectural Organization, Dilated Cardiomyopathy, and Heart FailureCell, 1997
- Autosomal recessive limbgirdle muscular dystrophy, LGMD2F, is caused by a mutation in the δ–sarcoglycan geneNature Genetics, 1996
- Disruption of muscle architecture and myocardial degeneration in mice lacking desmin.The Journal of cell biology, 1996
- Missense mutations in the adhalin gene linked to autosomal recessive muscular dystrophyCell, 1994
- Molecular Mechanism of Action of NicorandilJournal of Cardiovascular Pharmacology, 1992
- Microvascular spasm in the cardiomyopathic Syrian hamster: a preventable cause of focal myocardial necrosis.Circulation, 1982